Friday, Sep 11, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

Opioid makers marketed higher prescribing to boost sales and profits.

The Claim

Pharmaceutical companies have promoted the overprescription of opioid painkillers in order to increase their profits.

Verified by Lenz ·

The Short Version

Extensive evidence shows several opioid manufacturers promoted higher prescribing to increase sales and profits. That evidence includes Purdue Pharma’s federal guilty plea, congressional investigations, and peer-reviewed studies linking industry marketing and physician payments to increased opioid prescribing and overdose harm. The wording is broad, but the central claim is well supported.

Caveats

  • The strongest direct evidence concerns opioid manufacturers, especially Purdue Pharma; the claim should not be read as applying equally to every pharmaceutical company.
  • "Overprescription" is partly a clinical and policy judgment, though the evidence shows companies encouraged prescribing beyond safe, well-supported use.
  • Industry marketing was a major driver, but not the only one; prescriber behavior, regulatory failures, and broader health-system factors also contributed to the opioid crisis.

The Receipts

  1. Purdue Pharma L.P., et al. – Complaint

    State of Maine (Attorney General archives)

  2. Evaluation of the strategies opioid manufacturers used to recruit oncologists to use and overprescribe opioids: a qualitative study

    PubMed Central

  3. The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy

    PubMed Central (Journal of the American Pain Society / J Pain Symptom Manage review)

  4. Opioid Manufacturer Purdue Pharma Pleads Guilty to Fraud and Kickback Conspiracies

    U.S. Department of Justice

  5. HHS Publication – Facing Addiction in America: The Surgeon General’s Spotlight on Opioids (selected sections)

    U.S. Department of Health and Human Services / SAMHSA

  6. Drug Companies' Liability for the Opioid Epidemic

    National Library of Medicine (PubMed Central)

  7. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses

    JAMA Network Open

  8. The Stanford–Lancet Commission on the North American Opioid Crisis

    The Lancet (Stanford–Lancet Commission on the North American Opioid Crisis)

  9. What led to the opioid crisis—and how to fix it

    Harvard T.H. Chan School of Public Health

  10. Association Between Pharmaceutical Industry Marketing to Physicians and Opioid Prescribing

    JAMA Internal Medicine

+ 13 more sources — see the full list on Lenz

Filed Under

Opioid PainkillersPharmaceutical Companies

More Fact Checks